Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury.
Rivera P, Vargas A, Pastor A, Boronat A, López-Gambero AJ, Sánchez-Marín L, Medina-Vera D, Serrano A, Pavón FJ, de la Torre R, Agirregoitia E, Lucena MI, Rodríguez de Fonseca F, Decara J, Suárez J. Rivera P, et al. Among authors: pavon fj. Br J Pharmacol. 2020 Jul;177(14):3309-3326. doi: 10.1111/bph.15051. Epub 2020 Apr 15. Br J Pharmacol. 2020. PMID: 32167157 Free PMC article.
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
Pavon FJ, Bilbao A, Hernández-Folgado L, Cippitelli A, Jagerovic N, Abellán G, Rodríguez-Franco MA, Serrano A, Macias M, Gómez R, Navarro M, Goya P, Rodríguez de Fonseca F. Pavon FJ, et al. Neuropharmacology. 2006 Aug;51(2):358-66. doi: 10.1016/j.neuropharm.2006.03.029. Epub 2006 Jun 5. Neuropharmacology. 2006. PMID: 16750544
Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents.
Alvarado M, Goya P, Macías-González M, Pavón FJ, Serrano A, Jagerovic N, Elguero J, Gutiérrez-Rodríguez A, García-Granda S, Suardíaz M, Rodríguez de Fonseca F. Alvarado M, et al. Among authors: pavon fj. Bioorg Med Chem. 2008 Dec 1;16(23):10098-105. doi: 10.1016/j.bmc.2008.10.023. Epub 2008 Oct 14. Bioorg Med Chem. 2008. PMID: 18952442
Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions.
Rivera P, Romero-Zerbo Y, Pavón FJ, Serrano A, López-Ávalos MD, Cifuentes M, Grondona JM, Bermúdez-Silva FJ, Fernández-Llebrez P, de Fonseca FR, Suárez J, Pérez-Martín M. Rivera P, et al. Among authors: pavon fj. Eur J Neurosci. 2011 May;33(9):1577-86. doi: 10.1111/j.1460-9568.2011.07650.x. Epub 2011 Mar 14. Eur J Neurosci. 2011. PMID: 21395869
Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity.
Crespillo A, Alonso M, Vida M, Pavón FJ, Serrano A, Rivera P, Romero-Zerbo Y, Fernández-Llebrez P, Martínez A, Pérez-Valero V, Bermúdez-Silva FJ, Suárez J, de Fonseca FR. Crespillo A, et al. Among authors: pavon fj. Br J Pharmacol. 2011 Dec;164(7):1899-915. doi: 10.1111/j.1476-5381.2011.01477.x. Br J Pharmacol. 2011. PMID: 21557739 Free PMC article.
Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.
Alonso M, Serrano A, Vida M, Crespillo A, Hernandez-Folgado L, Jagerovic N, Goya P, Reyes-Cabello C, Perez-Valero V, Decara J, Macías-González M, Bermúdez-Silva FJ, Suárez J, Rodríguez de Fonseca F, Pavón FJ. Alonso M, et al. Among authors: pavon fj. Br J Pharmacol. 2012 Apr;165(7):2274-91. doi: 10.1111/j.1476-5381.2011.01698.x. Br J Pharmacol. 2012. PMID: 21951309 Free PMC article.
118 results